Literature DB >> 34142362

Molecular Dynamics Simulations Reveal the Modulated Mechanism of STING Conformation.

Li Chen1, Shuang Zhao1, Yanyan Zhu1, Yongsheng Liu1, Huiyu Li2, Qingjie Zhao3.   

Abstract

Stimulator of interferon genes (STING), which is an integral ER-membrane protein, could induce an antiviral state and boost antitumor immunity. Recent experiments reported that different small molecules could modulate the conformation of the STING. However, the mechanism of small molecules modulating the conformation of STING is still unknown. To illustrate the conformational modulated mechanism of STING by small molecules at atomic level, we investigated the interactions between STING and the small molecules: cGAMP and diABZI with molecular dynamics (MD) simulations method. Interestingly, we found that the residues of STING in the binding pocket are more flexible in the monomers of STING than that in the dimer of STING. We also demonstrated that cGAMP and diABZI have a similar binding mode to STING monomers/dimer, and π-π stacking interactions play important roles for the agonists and STING. Our study proposed mechanistic insights into the STING conformation modulated by small molecules and we suggested that the special molecule (e. g. diABZI) could induce the conformational transition of STING from the "open" monomers to the "closed" dimer state. Our research may provide a clue for the development of cancer immunotherapy.
© 2021. International Association of Scientists in the Interdisciplinary Areas.

Entities:  

Keywords:  Binding site; Modulated mechanism; Molecular dynamics simulation; STING; Small molecule; π–π stacking interaction

Mesh:

Substances:

Year:  2021        PMID: 34142362     DOI: 10.1007/s12539-021-00446-3

Source DB:  PubMed          Journal:  Interdiscip Sci        ISSN: 1867-1462            Impact factor:   2.233


  57 in total

1.  Design of amidobenzimidazole STING receptor agonists with systemic activity.

Authors:  Joshi M Ramanjulu; G Scott Pesiridis; Jingsong Yang; Nestor Concha; Robert Singhaus; Shu-Yun Zhang; Jean-Luc Tran; Patrick Moore; Stephanie Lehmann; H Christian Eberl; Marcel Muelbaier; Jessica L Schneck; Jim Clemens; Michael Adam; John Mehlmann; Joseph Romano; Angel Morales; James Kang; Lara Leister; Todd L Graybill; Adam K Charnley; Guosen Ye; Neysa Nevins; Kamelia Behnia; Amaya I Wolf; Viera Kasparcova; Kelvin Nurse; Liping Wang; Ana C Puhl; Yue Li; Michael Klein; Christopher B Hopson; Jeffrey Guss; Marcus Bantscheff; Giovanna Bergamini; Michael A Reilly; Yiqian Lian; Kevin J Duffy; Jerry Adams; Kevin P Foley; Peter J Gough; Robert W Marquis; James Smothers; Axel Hoos; John Bertin
Journal:  Nature       Date:  2018-11-07       Impact factor: 49.962

Review 2.  Pharmacological Modulation of the STING Pathway for Cancer Immunotherapy.

Authors:  Gilles Berger; Mickaël Marloye; Sean E Lawler
Journal:  Trends Mol Med       Date:  2019-03-15       Impact factor: 11.951

3.  Targeting DNA Damage Response Promotes Antitumor Immunity through STING-Mediated T-cell Activation in Small Cell Lung Cancer.

Authors:  Triparna Sen; B Leticia Rodriguez; Limo Chen; Carminia M Della Corte; Naoto Morikawa; Junya Fujimoto; Sandra Cristea; Thuyen Nguyen; Lixia Diao; Lerong Li; Youhong Fan; Yongbin Yang; Jing Wang; Bonnie S Glisson; Ignacio I Wistuba; Julien Sage; John V Heymach; Don L Gibbons; Lauren A Byers
Journal:  Cancer Discov       Date:  2019-02-18       Impact factor: 39.397

4.  STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors.

Authors:  Liufu Deng; Hua Liang; Meng Xu; Xuanming Yang; Byron Burnette; Ainhoa Arina; Xiao-Dong Li; Helena Mauceri; Michael Beckett; Thomas Darga; Xiaona Huang; Thomas F Gajewski; Zhijian J Chen; Yang-Xin Fu; Ralph R Weichselbaum
Journal:  Immunity       Date:  2014-11-06       Impact factor: 31.745

5.  STING Activation by Translocation from the ER Is Associated with Infection and Autoinflammatory Disease.

Authors:  Nicole Dobbs; Nikolay Burnaevskiy; Didi Chen; Vijay K Gonugunta; Neal M Alto; Nan Yan
Journal:  Cell Host Microbe       Date:  2015-07-30       Impact factor: 21.023

Review 6.  The cGAS-cGAMP-STING pathway connects DNA damage to inflammation, senescence, and cancer.

Authors:  Tuo Li; Zhijian J Chen
Journal:  J Exp Med       Date:  2018-04-05       Impact factor: 14.307

7.  Computational study on new natural compound agonists of stimulator of interferon genes (STING).

Authors:  Sheng Zhong; Weihang Li; Yang Bai; Bo Wu; Xinhui Wang; Shanshan Jiang; Yingjing Zhao; Jiaxin Ren; Hui Li; Rihua Jin
Journal:  PLoS One       Date:  2019-05-23       Impact factor: 3.240

8.  PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian Cancer.

Authors:  Liya Ding; Hye-Jung Kim; Qiwei Wang; Michael Kearns; Tao Jiang; Carolynn E Ohlson; Ben B Li; Shaozhen Xie; Joyce F Liu; Elizabeth H Stover; Brooke E Howitt; Roderick T Bronson; Suzan Lazo; Thomas M Roberts; Gordon J Freeman; Panagiotis A Konstantinopoulos; Ursula A Matulonis; Jean J Zhao
Journal:  Cell Rep       Date:  2018-12-11       Impact factor: 9.423

9.  Characterization of a Novel Human-Specific STING Agonist that Elicits Antiviral Activity Against Emerging Alphaviruses.

Authors:  Tina M Sali; Kara M Pryke; Jinu Abraham; Andrew Liu; Iris Archer; Rebecca Broeckel; Julia A Staverosky; Jessica L Smith; Ahmed Al-Shammari; Lisi Amsler; Kayla Sheridan; Aaron Nilsen; Daniel N Streblow; Victor R DeFilippis
Journal:  PLoS Pathog       Date:  2015-12-08       Impact factor: 6.823

10.  STING agonist therapy in combination with PD-1 immune checkpoint blockade enhances response to carboplatin chemotherapy in high-grade serous ovarian cancer.

Authors:  Abdi Ghaffari; Nichole Peterson; Kasra Khalaj; Natasha Vitkin; Andrew Robinson; Julie-Ann Francis; Madhuri Koti
Journal:  Br J Cancer       Date:  2018-07-26       Impact factor: 7.640

View more
  2 in total

1.  Control of STING Agonistic/Antagonistic Activity Using Amine-Skeleton-Based c-di-GMP Analogues.

Authors:  Yuta Yanase; Genichiro Tsuji; Miki Nakamura; Norihito Shibata; Yosuke Demizu
Journal:  Int J Mol Sci       Date:  2022-06-20       Impact factor: 6.208

2.  Computational discovery of binding mode of anti-TRBC1 antibody and predicted key amino acids of TRBC1.

Authors:  Jirakrit Saetang; Surasak Sangkhathat; Nawaphat Jangphattananont; Wannakorn Khopanlert; Jakrawadee Julamanee; Varomyalin Tipmanee
Journal:  Sci Rep       Date:  2022-02-02       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.